Durvalumab in Combination With Docetaxel, Cisplatin and 5-FU for Locally Advanced Head and Neck Squamous Cell Carcinoma
Condition(s):Head and Neck CancersLast Updated:January 3, 2019Unknown status
Hide Studies Not Open or Pending
Condition(s):Head and Neck CancersLast Updated:January 3, 2019Unknown status
Condition(s):Head and Neck CancerLast Updated:January 24, 2014Completed
Condition(s):Head and Neck CancerLast Updated:December 12, 2011Terminated
Condition(s):Cervical Cancer; Fallopian Tube Cancer; Head and Neck Cancer; Lung Cancer; Malignant Mesothelioma; Ovarian Cancer; Pancreatic Cancer; Primary Peritoneal Cavity CancerLast Updated:April 30, 2015Completed
Condition(s):Head and Neck CancerLast Updated:February 6, 2014Terminated
Condition(s):Head and Neck CancerLast Updated:June 22, 2023Completed
Condition(s):Head and Neck CancerLast Updated:August 21, 2020Completed
Condition(s):Head and Neck CancerLast Updated:July 9, 2018Completed
Condition(s):CancerLast Updated:January 18, 2019Terminated
Condition(s):Head and Neck CancerLast Updated:August 22, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.